Document is current
Any future updates will be listed below
-
Authors
Wróbel, Agata
Vandenberghe, Michel
Scott, Marietta
Jones, Frances
Matsuo, Tsuyoshi
Boothman, Anne-Marie
Whiteley, Jessica
Barker, Craig
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 26 February 2025
First Online: 4 April 2025
Declarations
:
: AstraZeneca has a governance framework and processes to ensure that commercial sources have appropriate patient consent and ethical approval in place for collection of samples for research purposes, including use by for-profit companies. The AstraZeneca Biobank in the UK is licensed by the Human Tissue Authority (Licence No. 12109) and has National Research Ethics Service Committee (NREC) approval as a Research Tissue Bank (RTB) (REC No 22/NW/0102), which covers the use of the samples for this project.
: Not applicable.
: All authors are employees of AstraZeneca. MV, MS, FJ, TM, A-MB, JW, and CB hold shares in AstraZeneca.
